Atlas Trials

An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

Clinical trial NCT02290301 · COMPLETED

Trial details

NCT number
NCT02290301
Sponsor
LG Life Sciences
Status
COMPLETED
Study type
OBSERVATIONAL
Type 2 Diabetes Mellitus
Start date
2013-06-28
Primary completion
2017-11-30
Enrollment
5180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.